Ampio Story

Planning to continue with Ampio Pharmaceuticals (NYSEMKT:AMPE) in January?
Using predictive technical analysis, we will analyze different prices and returns patterns and diagnose historical swings to determine the real value of Ampio Pharmaceuticals. In general, we focus on analyzing Ampio Pharmaceuticals stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Ampio Pharmaceuticals's daily price indicators and compare them against related drivers such as momentum indicators and various other types of predictive indicators. Using this methodology combined with a more conventional technical analysis and fundamental analysis, we attempt to find the most accurate representation of Ampio Pharmaceuticals's intrinsic value. In addition to deriving basic predictive indicators for Ampio Pharmaceuticals, we also check how macroeconomic factors affect Ampio Pharmaceuticals price patterns. Please read more on our technical analysis page or use our predictive modules below to complement your research. Sophisticated investors, who have witnessed many market ups and downs, frequently view the market will even out over time. This tendency of Ampio Pharmaceuticals' stock price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy. Please use the tools below to analyze the current value of Ampio Pharmaceuticals in the context of predictive analytics.

Hype Prediction Details

Intrinsic Valuation Details

Naive Forecast Details

1 Analysts Consensus Details

Please note, it is not enough to conduct a financial or market analysis of a single entity such as Ampio Pharmaceuticals. Your research has to be compared to or analyzed against Ampio Pharmaceuticals' peers to derive any actionable benefits. When done correctly, Ampio Pharmaceuticals' competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy towards taking a position in Ampio Pharmaceuticals.

Watch out for price decline

Please consider monitoring Ampio Pharmaceuticals on a daily basis if you are holding a position in it. Ampio Pharmaceuticals is trading at a penny-stock level, and the possibility of delisting is much higher compared to other equities. However, just because the stock is trading under one dollar, does not mean it will be marked for deletion. Most exchanges require public instruments, such as Ampio Pharmaceuticals stock to be traded above the $1 level to remain listed. If Ampio Pharmaceuticals stock price falls below $1 for 30 consecutive trading days, the exchange can delist it. Once the company reaches this point, they will be sent an initial price violation notice directly from an exchange.

How does Ampio Stands against Peers?

Analyzing Ampio Pharmaceuticals competition or peers my help you to expand the diversification possibilities of your existing portfolios and to get a better perspective on locking in new positions. Try to analyze the advantages of investing in traded instruments related to Ampio Pharmaceuticals across multiple sectors and thematic ideas. A good competitive analysis can cover a lot of different areas. But what areas to choose depends on who you are. The more exhaustive you are in your analysis, the more effective your competitive analysis will be. Check out Ampio Pharmaceuticals Competition Details

How Ampio utilizes its cash?

To perform a cash flow analysis of Ampio Pharmaceuticals, investors first need to understand how to read the cash flow statement. A cash flow statement shows the amount of cash Ampio Pharmaceuticals is receiving and how much cash it distributes out in a given period. The Ampio Pharmaceuticals cash flow statement breaks down these inflows and outflows into different buckets, including operating activities, investing activities, and financing activities. Ampio Pharmaceuticals Net Cash Flow from Operations is projected to decrease significantly based on the last few years of reporting. The past year's Net Cash Flow from Operations was at (13.84 Million)

About Contributor